Paramagnetic rim lesions, or areas of damage in the brain and spinal cord, could be a useful tool for diagnosing MS, a study ...

As cold and flu season approaches, columnist Leigh Anne Nelson shares her experience getting vaccinated against the flu and pneumonia.

The patent comes months after Immunic Therapeutics announced CALLIPER study results, which tested vidofludimus calcium in ...

A generic formulation of Zeposia will be manufactured and supplied by Netherlands-based Synthon, upon final approval by the ...

TG Therapeutics has started enrolling adults with relapsing forms of MS for a Phase 3 trial testing a subcutaneous ...

Guess writer Aranzazu Calzado says her digestive and urinary problems are like being on a bad roller coaster. But she's ...

The Multiple Sclerosis Disease Activity test, which measures proteins to assess disease activity, has been available in the U ...

Ocrevus rapidly depletes immune B-cells in people with MS, but ongoing treatment also leads to changes in immune T-cells, a ...

A new partnership will bring three new medications to the Middle East and North Africa, including an Ocrevus biosimilar drug ...

Most children with MS have chronic lesions that slowly get bigger over time, but their frequency doesn't correlate with ...

The FDA gave Hope Bioscience's stem cell therapy RMAT designation after clinical data suggested it may improve life for ...

Most MS neurologists in the US have received physician pharma payments, and a study suggests this may influence their ...